A study has shown that AstraZeneca vaccines …

An official British study concluded that the AstraZeneca and Pfizer vaccines are effective against the Indian variant of the coronavirus. Following the publication of the results, the British authorities sThey were confident that the restrictions still in force in the country could be lifted from June 21..

“There is optimism (being able to move forward without refinement), if people continue to observe all safety measuresJenny Harries, executive director of the UK Health Security Agency, the Department of Health’s body responsible for health care and response to infectious epidemics, told the BBC.

Despite the optimism, Harries insisted on do not relax in the care, especially in the North West of England, where the Indian variant has become the predominant variant.

For his part, the British Minister for Health, Matt Hancock, also he said he was “increasingly confident” that the government can meet its timetable for exiting the third lockdown.

The study

The statements came after the publication of a study conducted between April 5 and May 6 by Public Health England, an agency of the UK Department of Health, which found that Pfizer’s coronavirus vaccine is 88% effective against the Indian mutation after two doses, while AstraZeneca’s was 60% effective after both doses.

The study also found that the two vaccines, at two doses, were equally effective in symptomatic cases against the Indian and English variants. In exchange, with a single dose, the efficacy against symptomatic cases of the Indian mutation was only 33% three weeks after application, compared to 50% against the English mutation.

The study was carried out after the expansion of the Indian variant in the UK (over 2,880 cases have been recorded), due to concerns from UK authorities that this increase could jeopardize the country’s hitherto successful vaccination plan. government to gradually get out of the third confinement, decreed last December after the discovery of the English variant.

In the UK, more than 37.7 million people, representing 72% of the adult population, have received at least one dose of a certain coronavirus vaccine, while the percentage of the population who received both doses has reached this end 42% of the week.